Abstract
The spinal cord has a poor ability to regenerate after an injury, which may be due to cell loss, cyst formation, inflammation, and scarring. A promising approach to treating a spinal cord injury (SCI) is the use of biomaterials. We have developed a novel hydrogel scaffold fabricated from oligo(poly(ethylene glycol) fumarate) (OPF) as a 0.08 mm thick sheet containing polymer ridges and a cell-attractive surface on the other side. When the cells are cultured on OPF via chemical patterning, the cells attach, align, and deposit ECM along the direction of the pattern. Animals implanted with the rolled scaffold sheets had greater hindlimb recovery compared to that of the multichannel scaffold control, which is likely due to the greater number of axons growing across it. The immune cell number (microglia or hemopoietic cells: 50–120 cells/mm2 in all conditions), scarring (5–10% in all conditions), and ECM deposits (Laminin or Fibronectin: approximately 10–20% in all conditions) were equal in all conditions. Overall, the results suggest that the scaffold sheets promote axon outgrowth that can be guided across the scaffold, thereby promoting hindlimb recovery. This study provides a hydrogel scaffold construct that can be used in vitro for cell characterization or in vivo for future neuroprosthetics, devices, or cell and ECM delivery.
Keywords: axon regeneration, biomaterials, immune cells, machine learning, mesenchymal stromal cells (MSCs), oligo(poly(ethylene glycol)) fumarate, Schwann cells, spinal cord injury, titanium dioxide, scarring
1. Introduction
The utilization of tissue engineering and material science in regenerative medicine for the treatment of a spinal cord injury (SCI) presents an opportunity to modify the hostile microenvironment to promote regeneration after the injury. Traumatic SCIs occur due to an insult of the vertebral column, resulting in the contusion, compression, laceration, or transection of the spinal cord. This primary injury leads to a host of secondary injury events, such as inflammation, cell loss, scarring, and cavitation, which not only create a hostile microenvironment, but a physical gap that impedes regeneration [1]. Hydrogels can be constructed into scaffolding for axons to regenerate across, thereby bridging the injury. Physical and chemical configurations of the scaffold are important factors to consider when developing new designs and biomaterials. They should match the existing spinal cord environment and hinder the regeneration as little as possible. Attributes such as stiffness, permeability, swelling, strength, and degradation kinetics are the most important characteristics, which define the reaction of the surrounding tissue to the foreign implant [2]. In addition, the physical characteristics of scaffolds can change due to degradation and physiological stressors, which are ideally tested in vivo [3]. The macro- and micro-architecture of the scaffold can greatly affect its ability to promote regeneration and recovery following an SCI [4]. Many considerations in the type of material or design play an important role in balancing the effects of regeneration verses inflammation or scarring because of the introduction of a foreign object.
Several scaffold macro-architectures designs have been investigated. These designs fall into five broad categories consisting of a spongey cylinder, single tube, channels, an open path with a core, and an open path without core [5]. Open-path scaffolds can increase axon regeneration, while maintaining the defect size, while other scaffold designs do not show as much axon growth and have an increased defect size [5]. However, other studies have demonstrated that multichannel designs can aid axon regeneration and have reduced cysts sizes, and they have been designed to match the spatial distribution of spinal cord tracts [6,7]. Another influence on axon regeneration is the diameter of the channels, where often reducing the channel size can increase the axon count [8]. For example, reducing the channel size from 660 μm to 450 μm in diameter nearly doubled the number of axons that grew [8]. Channels as small as 200 μm have been shown to promote axon regeneration, and the in vitro characterization of astrocytes shows that smaller-diameter scaffolds alter alignment and proliferation [9,10]. Another strategy to improve alignment involved using grooves or ridges to introduce orientation via methods such as lithography [11,12], molding [13,14], or 3D biofabrication [15,16]. Our group recently developed a method via which the surface topology could be added to a water-rich hydrogel via chemical processing utilizing hydrolysis [17]. This surface chemistry uses a coating of titanium dioxide (TiO2) to layer a surface of phosphonic acid to create a self-assembled monolayer of phosphonates (SAMP; TiSAMP) that is only a few molecular layers high and can be patterned to be 30 μm wide (Figure 1A). When it is patterned, the fibroblasts extend and deposit ECM along the direction of the pattern [18].
One concern with implantable biomaterials, particularly as further modifications are made, is the biocompatibility of the material to the host tissue. It has been often observed that in matter of weeks, implant materials cause foreign body reaction that results in the accumulation of collagenous capsule and fibrosis with low vascularity and inflammation [19,20,21]. One approach has been to reduce the area of the biomaterial available to interact with infiltrating cells or tissue; however, this often leads to fibrosis at the tissue–biomaterial interface [22,23]. Factors such as porosity, hydrophobicity, surface topography, stiffness, surface chemistry, and other active components can influence inflammation [24]. For example, the ability of biomaterials to bind damage-associated molecular patterns (DAMPs) released from injured tissues may lead to greater inflammation around the biomaterial due to recognition by immune cells. As the material is degraded, the DAMPs may re-release, leading macrophage activation and chronic inflammation [25,26]. Therefore, novel scaffold designs, modification, and biomaterials should be tested to ensure scarring or inflammation is not enhanced.
We have developed a hydrogel composed of oligo(poly(ethylene glycol)fumarate) (OPF) that is biodegradable, porous, and biomechanically similar to the spinal cord [27,28]. When it is fabricated in a multichannel design, it can reduce scarring and cyst formation and can induce greater axon outgrowth than poly(lactic-co-glycolic acid) (PLGA)- and poly(caprolactone fumarate) (PCLF)-based scaffolds can [28,29]. OPF can be easily utilized for combinatorial therapy via combining them with cells, drug eluting microspheres, extracellular matrix (ECM) proteins, or modifying the material with additional characteristics, such as a positive charge or improved electroconductivity [13,28,29,30,31,32,33,34,35]. All these modifications aim to improve regeneration and recovery following an SCI.
One important observation to come from these studies is that directing axon growth across the scaffold is important, and although the multichannel design helps achieve this, many of the axons still grow on the outside surface of the scaffold. In an aim to improve directed axon growth through the scaffold, we modified the design of the scaffold to introduce a greater internal surface area by fabricating the scaffold as a ridged sheet [13]. The ridges help to direct neurite growth in a bidirectional manner, and when they are placed closer together, they can increase the number of neurites per surface area [13]. However, there is a limit to how close ridges can be placed together using molding techniques. To overcome this obstacle, we created a process by which TiO2 can be used to layer SAMP on hydrogels within micrometers of each other [18]. This study is the first application of these rolled scaffolds containing TiSAMP in a rodent SCI model. Since in vivo cellular interactions with biomaterials are more complex than those that occur in vitro and these influences can affect axon regeneration, this is an important step toward possible future human use. This current study demonstrates that an open-design, ridged scaffold sheet via a cell-attractive TiSAMP chemical treatment (Figure 1) improves axon outgrowth further without increasing inflammation and scarring as compared to that of the more commonly used multichannel scaffold design. In addition, this study details a method with which machine learning algorithms can be used to analyze immune cell infiltration and scarring following scaffold implantation in a fast, non-biased manner.
2. Results
2.1. Cultured Mesenchymal Stromal Cells form Spheres on Ridged Surfaces
OPF+ scaffold sheets were fabricated with 0.1 mm high ridges spaced 0.4 mm apart on one side. The other side contained a bare polymer. Our previous study demonstrated that ECM protein-coated, ridged OPF+ sheets promoted Schwann cell and neuronal alignment and outgrowth along the ridge in vitro [13]. However, different cell types respond differently to topographic cues (ridges or material stiffness); so, two commonly investigated cell types for SCI treatment (mesenchymal stromal cells (MSCs) and Schwann cells) were compared. Human MSC (hMSCs) and rat Schwann cells were grown on the ridged OPF+ sheet and glass coverslips (Figure 2A–D). At 3 days in the culture, the cells were found primarily on or near the ridges on the OPF+ sheet (Figure 2A,B; white arrows indicate ridges). The Schwann cells adhered and spread along the ridges (Figure 2B), while hMSCs did not spread, but instead adhered as large cell clusters (Figure 2A). In contrast, when they were grown on glass coverslips (Figure 2C,D), all the cell types exhibit their normal, stereotypical, well-spread, and flat shapes.
Since these OPF+ sheets were not coated with any ECM molecules other than those found in the media, we coated the OPF+ ridged sheets with PLL, laminin, or fibronectin protein coats. Again, we found that the hMSCs were found mostly on the ridges as cell clusters (Figure 3A–D) after 3 days in the culture. To test if these clusters were viable and exhibited a normal morphology, they were picked and plated in normal culture dishes (Figure 3E). The clusters were shown to spread on the culture dish and grow normally.
Next, we tested if this behavior of the cells was due to material stiffness or the topography. The hMSC sphere contains multiple nucelli, and the phalloidin does not extend out on the material (Figure 4A). When hMSCs are grown on the flat side of the OPF+ scaffold, we found that the cells adhered to the material in a flat manner such as it does on glass and plastic (Figure 4B). Staining for actin with phalloidin, we show that the cytoskeletal structure looks like that of hMSCs grown on glass coverslips (Figure 4C). These results suggest that the 3D shape formed by the 0.1 mm high ridges induces cell clusters rather than the material being softer than plastic/glass is.
2.2. Mesenchymal Stromal Cells, Schwann Cells, and DRG Neurons Attach to TiSAMP and Extend along the Chemical Pattern
We fabricated ridged OPF scaffold sheets and deposited TiSAMP on the un-ridged side, which was either unpatterned (full TiSAMP) or patterned with 30 μm TiSAMP by 30 μm polymer (30 × 30 TiSAMP), using a shadow masking technique (Figure 1). The chemical processing of the OPF hydrogel scaffolds with TiSAMP has the advantages of being only a few molecular layers thick and can be patterned closer together than molding ridges can. The effect of the TiSAMP surface on outgrowth and ECM deposition by hMSCs, rat Schwann cells, and neurons was investigated. hMSCs, Schwann cells, and dispersed DRG neurons were plated on OPF scaffolds with no TiSAMP, full TiSAMP coating, and patterned 30 × 30 TiSAMP for 7 days. The cells adhered in a random orientation on the OPF (Figure 5A) and full TiSAMP (Figure 5B and Figure 6A), although the cells adhered more sparsely on the untreated OPF. On the OPF 30 × 30 TiSAMP, the cells aligned along the chemical pattern in a bidirectional fashion (Figure 5C). In some cases, the DRG neurons extended on the bare polymer, but then join at the contralateral pattern, still preferring the chemical’s bidirectional pattern, as detected via the anti-tubulin staining of neurites (Figure 5C and Figure 6B). These results demonstrate that neurite outgrowth is enhanced on the TiSAMP material, and alignment can be promoted via the striped pattern. Attachment and elongation are superior to that on the bare polymer, and therefore, may aid axon regeneration across the gap in the SCI animal model.
The different cell types may interact with the biomaterial via depositing ECM. hMSCs, Schwann cells, and a co-culture of hMSCs and Schwann cells were stained for fibronectin and laminin production. The co-cultured cells, such as the cells cultured alone did, aligned along the chemical pattern (Figure 7A–C). hMSCs produce more fibronectin alone than the Schwann cells did, although the difference was not statistically significant (Figure 7D,E; hMSC = 17.02 ± 6.43 mean gray value, and Schwann cells = 7.57 ± 2.87 mean gray value). The Schwann cells produced more laminin than hMSCs did (Figure 7G,H; hMSC = 43.33 ± 9.10 mean gray value, and Schwann cells = 161.9 ± 32.77 mean gray value, p = 0.013). The ECM deposits were in the orientation of chemical patterning. Co-cultures can deposit both ECM types (Figure 7F,I). Co-culturing hMSCs and Schwann cells resulted in greater fibronectin deposits (188.9 ± 37.67 mean gray value) than those produced using the Schwann cells (Figure 7J; p = 0.0004) or MSCs alone (p = 0.0003), suggesting that both cell types produce fibronectin. Co-culture staining for laminin was not significantly different from that of Schwann cells alone, but it was much better than using hMSCs alone (Figure 7K; hMSCs = 43.33 ± 9.10 mean gray value, co-culture = 147.50 ± 17.97 mean gray value, p = 0.0367) indicating that Schwann cells are primarily responsible for producing laminin in this system. DRG neurons were plated onto Schwann cell cultures, and DRG neurites were visualized via anti β-tubulin staining, which shows that some neurites extended along the fibronectin component of the ECM (Figure 8A,B). Together, these results indicate this TiSAMP-patterned material can support cell attachment, neurite outgrowth, and ECM deposition, all of which are important for SCI repair.
2.3. Rolled Scaffolds Have Equal Number of Hemopoietic Cells, Microglia, and Other Cell Types as Multichannel Scaffolds
The in vitro data demonstrate that TiSAMP is cell- and protein (ECM)-attractive as more can bind to the surface than the number of those on bare OPF surfaces. While enhancement of axon regeneration is an important goal for treatment of an SCI, any modifications (chemical or architectural) to the implanted polymer scaffolds should not lead to increased negative side effects. Foreign body reactions leading to inflammation and scarring have been a long-time concern for neuroprosthetic and biomaterial scientists [33,34,36,37]. The cell- and protein-attractive surface may lead to greater cell infiltration into the scaffold, resulting in enhanced inflammation or fibrosis/scarring. Immunostaining was performed with CD45 to label hemopoietic cells, Iba1 to label with microglia/macrophages, and the DAPI counterstain to label all cell nuclei to determine the infiltration of cells into the scaffold after transplantation (Figure 9A–D,A1–D1: magnified areas from the central scaffold; A2–D2: magnified areas from the outer scaffold). A machine learning approach was used to identify and quantify the cell populations in a quick and non-biased manner (details in Supplementary Figure S3). All animals implanted with OPF scaffolds had equal numbers of hemopoietic cells (Figure 9E and Supplementary Figure S1A), microglia/macrophages (Figure 9F and Supplementary Figure S1B), and total number of cells (Figure 9G and Supplementary Figure S1C), which were equally distributed throughout the lengths of the scaffolds. The average numbers of hemopoietic cells were 82.88 ± 21.37 cells/mm2 for untreated OPF, 50.12 ± 5.19 cells/mm2 for full TiSAMP, 79.11 ± 19.90 cells/mm2 for 30 × 30 TiSAMP, and 91.65 ± 33.74 cells/mm2 for the seven-channel scaffolds (Figure 9E). The numbers of microglia/macrophage were 73.78 ± 27.13 cells/mm2 for untreated OPF, 55.66 ± 23.96 cells/mm2 for full TiSAMP, 90.57 ± 27.25 cells/mm2 for 30 × 30 TiSAMP, and 120.4 ± 37.34cells/mm2 for the seven-channel scaffolds (Figure 9F). Interestingly, these immune cell types only consisted of a small proportion of the total cells, which averaged 4592.4 ± 221.0 cells/mm2 for untreated OPF, 3956.3 ± 166.4 cells/mm2 for full TiSAMP, 3558.6 ± 375.4 cells/mm2 for 30 × 30 TiSAMP, and 4588.5 ± 80.9 cells/mm2 for the seven-channel scaffolds (Figure 9G). These results show no statistical differences in the types and numbers of cells that interacted with these different scaffolds after implantation.
2.4. Rolled Scaffolds Have Equivalent Deposits of Collagen, Laminin, and Fibronectin as Those in Multichannel Scaffolds
The extra open space could have been recognized as cavitation, or chemical processing could have been detected as an additional foreign object resulting in greater scarring. In addition, it has been noted that cells infiltrate into the scaffold and may contribute by laying down ECM on the TiSAMP surfaces. Trichrome staining was performed to determine the amount of collagen fibrotic scarring present in the rolled scaffolds compared to the seven-channel scaffolds (Figure 10A). A machine learning approach was employed to recognize the whole tissue and the scarred area from whole slide scans (details in Supplementary Figure S4). There was no statistical difference in the amount of collagen scar present across the scaffold types, with a roughly equal distribution across the length of the scaffold (Figure 10B and Supplementary Figure S2). The average percentages of scar area present were 3.62 ± 1.31% for untreated OPF, 4.73 ± 1.51% for full TiSAMP, 9.58 ± 1.98% for 30 × 30 TiSAMP, and 3.79 ± 1.69% for the seven-channel scaffolds (Figure 10B). A larger amount of the scar was observed on the outer surface of the rolled scaffolds than that which was internal.
Since cultured cells can deposit ECM on the chemical pattern, which neurites can grow on and weave through (see Figure 7 and Figure 8), infiltrating cells may also contribute to the amount of ECM on the chemically processed scaffolds. Fibronectin (Figure 11A,D,G,J) and laminin (Figure 11B,E,H,K) are some of the major ECM types in the spinal cord. Equivalent amounts of fibronectin and laminin were detected across the lengths of the scaffolds, independent of whether they were chemically treated or untreated scaffolds (Figure 11C,F,I–K). The total contribution of ECM to the surface areas of the scaffolds was 10–20%. This indicates that the presence of the TiSAMP coat did not enhance or inhibit ECM deposition.
2.5. Implantation of Rolled Scaffolds Results in More Axon Growth through the Scaffold and Improved Hindlimb Function Compared to Those of Multichannel Scaffolds
Chemically treated, ridged OPF sheets (0.4 mm spaced ridges on one side and either no chemical treatment, full TiSAMP treatment, or patterned 30 × 30 TiSAMP treatment on the other side) were rolled into a single-channel OPF scaffold and implanted into rats following thoracic (T9) transection. The effect on axon outgrowth, inflammation, scarring, and behavioral recovery was compared between animals implanted with rolled OPF sheets and OPF in a multichannel (seven channel) design in the absence of any added ECM or Matrigel over a 5-week period. The immunostaining of axons with β-tubulin (Figure 12A–D) revealed that all three rolled scaffolds (untreated OPF contained 2936 ± 580.2 axons/mm2, p = 0.0091; full TiSAMP had 2579 ± 611.0 axons/mm2, p = 0.0243; 30 × 30 TiSAMP had 1733 ± 949.0 axons/mm2, p = ns) had greater axon counts than the seven-channel scaffold did (125.9 ± 26.92 axons/mm2, Figure 12E). Much of the β-tubulin staining in the seven-channel scaffold were cells that contained β-tubulin, possibly via the digestion of axonal/neuronal debris (axons are identified via punctate β-tubulin staining with no DAPI nuclei, whereas cells are indicated via β-tubulin staining containing DAPI nuclei; Figure 12D,D1: magnification of central scaffold and D2: magnification of outer scaffold). Although there is an increase in the number of axons in the scaffold, axons growing on the outside surface were still evident (Figure 12(A2–C2)). The rolled sheet design, with a more open surface area available in the same size scaffold as that of the seven-channel design, contained more axons per mm2, perhaps indicating a greater regenerative potential to make connections across the lesion.
The BBB test is an open field test that measures hindlimb function based on a 21-point score, with 21 being normal function, a score of 8 representing that they are able to sweep with no weight support, and 0 being no function. To obtain the BBB score, we averaged two blinded scorers weekly over the 5-week period. The BBB scores matched the trend from the axons counts, where the animals implanted with either of the three rolled scaffolds had significantly greater scores from weeks 1 to 4 than those the animals implanted with the seven-channel scaffold (Figure 12F). The greatest difference in the BBB score was seen at week 3 (seven-channel scaffold score was 0.69 ± 0.28 vs. untreated OPF score of 4.00 ± 0.74, p = 0.015; full TiSAMP score of 4.32 ± 1.05, p = 0.048; 30 × 30 TiSAMP score of 4.54 ± 0.75, p = 0.006) and week 4 (seven-channel scaffold score was 0.59 ± 0.19 vs. untreated OPF score of 3.68 ± 0.55, p = 0.004; full TiSAMP score of 5.50 ± 0.96, p = 0.012; 30 × 30 TiSAMP score of 5.25 ± 0.81, p = 0.007). The animals implanted with the seven-channel scaffolds improved at week 5 to the point that the greater BBB scores of the rolled scaffolds were not significantly greater. These results suggest that a rolled scaffold design may facilitate the more rapid recovery of function perhaps via increasing the number of axons able to traverse the scaffold.
3. Discussion
Anatomical and functional recovery following an SCI requires a growth-permissive environment that guides axons across the injury to help bridge the gap and reform connections. Both short relay reconnections and the regeneration of long tracts can promote functional recovery [38]. One way to promote these reconnections is to provide appropriate growth environments with topographical cues, which can be achieved via the introduction of hydrogel scaffolds. This study demonstrates that chemically patterned TiSAMP OPF sheets can promote the alignment and outgrowth of cultured hMSCs, Schwann cells, and dispersed DRG neurons. The ECM matrix produced by these cells can also align on the patterned surface, and the use of multiple cell types can contribute different ECM types. In vivo, rats implanted with the open-spaced, rolled scaffold sheets with ridges had a greater degree of axon regrowth through the scaffold with improved early hindlimb recovery compared to that of the rats implanted with the multichannel scaffold without any increased inflammation, scarring, or ECM (laminin and fibronectin) deposition. Lastly, research on this topic is slowed down by in-depth histological analysis that is often required. We demonstrated a method by which machine learning utilizing neural networks can aid in the analysis of these data sets in a fast, non-bias mannered, allowing for the rapid characterization of implanted materials using an open-source software, QuPath (v0.3.2).
Attributes such as stiffness, permeability, swelling, strength and degradation kinetics are the important characteristics, which define the reaction of the surrounding tissue to the foreign implant [2]. The choice of the right biomaterials is, therefore, an important step in the subsequent development of a spinal cord scaffold. Hydrogels, which are water-absorbing cross-linked polymer networks, can simulate the mechanical and physical properties of the adjacent spinal cord [39]. However, hydrogels have lower protein adsorption, which reduces cell adhesion and structural support [40]. This problem is mediated via incorporating ECM proteins into the scaffold, adding adhesion sites, or via chemical processing, as demonstrated in this study. Biomaterials can be divided into two classes of being naturally and synthetically derived [41]. The natural biomaterials investigated for SCIs are collagen, hyaluronic acid, chitosan, gelatin, agarose, alginate, and fibrin [42,43,44,45,46,47,48,49]. Naturally derived biomaterials can have composition that is similar to that of the spinal cord and, generally, are thought to have good biocompatibility, biodegradability, low toxicity, intrinsic cellular interaction, and biological functionality [50]. However, synthetical polymers allow a wider range of customization via adjusting their composition and combining different polymers to create new ones [51]. Commonly used synthetic polymers are often composed of poly(lactic acid) (PLA), poly(lactic-co-glycolic acid) (PLGA), polyethylene glycol (PEG), and non-biodegradable hydrogels such as poly(2-hydroxyethyl methacrylate) (pHEMA) [52,53,54,55]. OPF scaffolds are hydrogels that have a PEG base and have a fumarate moeity [27]. By changing the ratios and concentrations of the cross-linker and polymer in the precursor solution, its biophysical properties can be fine-tuned to fit the demand of the target tissue [27]. In comparison to PLGA and poly(ε-caprolactone fumarate) (PCLF) scaffolds, OPF and positively charged OPF+ scaffolds have the most similar mechanical properties to that of spinal cord tissue [28].
Notably, the degree of axon regeneration, even without the aid of ECM molecules, cells, or other factors, was greater in the rolled scaffold sheet design than it was in the multichannel design. Previous studies have demonstrated that open-path polycaprolactone (PCL) scaffolds increase axon regrowth and have a smaller deficit size as compared to those of multichannel, tube, or cylinder designs [5]. However, multichannel scaffolds with an increased number of smaller channels can encourage greater axon regrowth as well [8]. This could partially be due to the larger channel scaffolds having larger fibrous rims. Our rolled scaffold design has a larger surface area than that of the multichannel design and is somewhat a hybrid of an open path and multichannel scaffold since the ridges do act as spacers between the layers and segment the open space. The use of rolled scaffolds, with their greater open spaces, did not result in any greater amount of fibrotic collagen scarring than the multichannel scaffolds did. This was an important consideration since previous studies with multichannel scaffolds demonstrated collagen-dense scarring in the area of the open channels and host interface surfaces [29,56]. Additional topographical cues are added via TiSAMP chemical patterning, which, in vitro helps to align and guide the growth of different cell types. This approach is most similar to the use of fibrils or grooves micro-architectures to promote elongation and alignment [13,57]. A PLGA scaffold designed as a cylindrical nanofibrous scaffold was demonstrated to help align cells and induce their proliferation in vitro, and after transplantation in a left lateral hemisection, it induced superior hindlimb function in lesion control animals in a BBB open field test [58]. Our study demonstrated a similar level of hindlimb function recovery when the rolled OPF scaffold sheet was implanted following a complete transection. Although, in the absence of added factors such as the ECM or cells, all three rolled scaffold types had a similar level of recovery and axon regrowth throughout the scaffold. However, all of the rolled scaffold sheets in this study have ridges that we have previously shown can guide neurites in vitro alone [13]. Future studies should explore whether adding aligned ECM or cells, which is aided by the TiSAMP patterning, can further enhance regeneration and recovery.
MSCs are a popular cell type for use in CNS injuries and disease treatments. They can provide trophic support, modulate the immune system, aid tissue preservation, and promote angiogenesis [59,60]. On ridged surfaces, MSCs preferentially adhere to the ridges, instead of the adjacent flat area, thereby forming spheres. On flat OPF sheets, glass, or plastic, MSCs will have a stereotypical flat morphology. The addition of ECM protein coats did not aid in flat attachment to the ridged OPF scaffold. The MSCs produced collagen IV on the softer, spinal cord, such as the OPF material. When MSCs were grown on the OPF surface containing patterned TiSAMP, which was only a few molecular layers higher than the polymer spacing was, they attached and aligned on the scaffold without forming spheres. Taken together, this demonstrates the importance of the stiffness and physical structure of surfaces where the MSCs are expected to adhere to or engraft onto. When they are used for treatments for CNS injures and disorders, cells are injected into or on top of soft surfaces, such as the brain or spinal cord. However, many of the studies that are conducted to characterize MSCs in vitro use glass or plastic surfaces [61,62,63]. In this study, we demonstrate that cell characteristics can change depending on the surface morphology and stiffness. Gene expression changes, cell adhesion properties, and changes in proliferation have been previously described to be influenced by the structure and stiffness of the surface that the MSCs are grown on top of [64,65]. This scaffold, with or without TiSAMP, introduces a new way to investigate cells on surfaces that are more similar the biomechanical ones that they will be implanted on. In addition, the scaffold also presents a way to deliver pre-cultured cells and ECM to the spinal cord in future studies, while maximizing the surface area and promoting bidirectional orientation to bridge the gap after an injury.
Schwann cells are another popular cell therapy choice for SCIs as they are the myelinating cell type of the peripheral nervous system and may encourage regeneration via the secretion of trophic factors, ECM proteins, and physical scaffolding [1,66,67]. Schwann cells are also affected by material stiffness and elasticity. When they are grown on softer surfaces (0.5–4 kPa), Schwann cells exhibit a rounded morphology and reduced motility and proliferation [68,69], whereas the stiffer surfaces of Schwann cells have a bipolar morphology with increased motility and proliferation. Surface stiffness can also have important functional relevance since during the development of peripheral nerves, the stiffness changes from around 6kPa when myelination starts to about 50 kPa during adulthood [70]. The results in this study show that Schwann cells grown on OPF scaffolds with TiSAMP attach and elongate on the chemical. The same stiffness-dependent effects of hMSCs were not seen.
We also investigated the ability of Schwann cells to deposit ECM on the scaffolds. The amount of ECM produced by Schwann cells may be limited, and in the current study, they produced a little amount of fibronectin. Other cell types, such as fibroblasts, have been used to enhance the depositing of factors and ECM from Schwann cells [71]. In this study, we tested the capability of Schwann Cells to synergize ECM production with hMSCs. Human MSCs can produce various ECM components, such as fibronectin, laminin, collagen I and Tenascin-C [72], which can act as a substrate for Schwann cells. The co-culture of Schwann cells and hMSCs increased the fibronectin deposits by five-fold more than when they were cultured alone. Schwann cells were also able to add greater laminin components to the ECM in co-culture than those when the hMSCs were cultured alone. In addition, the ECM fibrils aligned with the direction of TiSAMP patterning. Certain ECM proteins are well known to assist nerve regeneration. During development, the expression of laminin and fibronectin coincides with the migration of neurons [73]. Laminin can guide axons and neurites, while fibronectin has a role in regulating cell differentiation, migration, and adhesion [74,75,76,77]. Various endogenous cells have been known to infiltrate scaffolds [32,57,78,79] and may contribute to their ECM composition. Since the TiSAMP chemical process aided in the deposition of ECM from cultured cells, infiltrating endogenous cell types may deposit ECM, which could aid regeneration. Following the trend of axon regrowth, all the implanted scaffold sheets had equal depositions of laminin and fibronectin. Since only a small proportion of the total cells were immune cells and, on average, the laminin and fibronectin areas were greater than the scar area was, ECM depositing by endogenous cells could have been beneficial to axon regrowth. This finding also provides parameters for the investigation of implanting exogenous ECMs, since endogenous cell infiltration can contribute to the overall composition. Therefore, strategies influencing the endogenous cell expression of inhibitory products in combination with biomaterials remains important.
This study takes a novel approach to fabricating a scaffold for spinal cord repair via using a ridged, flat sheet design molded on a grooved Teflon plate, and then optimized using a new method to layer titanium dioxide and a self-assembled monolayer of phosphoric acid on hydrogel surfaces to increase the adhesion points on the scaffold. For implantation, the scaffold sheet was then rolled into the diameter of the spinal cord into a single tube OPF scaffold for implantation, or it could be used as flat sheets in a culture. However, alternative methods to fabricating scaffolds exist, such as electrospinning, self-assembly, solvent casting, and 3D bioprinting [80,81,82,83]. Three-dimensional bioprinting, in particular, has an interesting clinical application in creating patient-specific scaffolds using images captured via computer tomography or magnetic resonance imaging [84]. The materials used in this study can be adapted for other fabrication processes to aid in developing patient-specific constructions. We demonstrate that greater open spaces aid in axon regeneration, which could be achieved via using a spiral ridged design. The dimensions of these ridges and spaces, as well as anchoring enhancements using TiSAMP, can be adapted into other future designs.
4. Conclusions
Overall, this study demonstrates that OPF scaffolds fabricated as ridged sheets with chemical patterns can promote the alignment and outgrowth of cells in a bidirectional manner. This patterning also influences the directionality of produced factors, such as the ECM. When they are rolled and implanted into rats after spinal cord transection, the rolled scaffold sheets promote greater axon regeneration than the multichannel scaffolds do. We noted no additional immune cell infiltration or scarring. ECM depositing on the scaffold by endogenous cells may contribute to axon outgrowth. As the purpose of the study was to characterize the in vivo effects of the scaffold, this study was conducted up to 5 weeks post-injury. The first 4 weeks constituted the acute and subacute phases of the SCI, where inflammation, regeneration, and scar formation play important roles. However, it is important for the authors of future studies to explore the role of this scaffold during the chronic phase, particularly if it is functionalized with biologics. Future studies can use this scaffold design with the TiSAMP coating to deliver cells or functionalize the surface with ECMs. The ECM is comprised of fibrillar proteins and additional factors that are not only biocompatible and bioactive, but also reiterate the structural and compositional characteristics of the native environment [71,85]. Altering the types of cells, physical conditions, or the culture media make it possible to obtain a great diversity of specifically designed ECMs that are suitable for different implementations [71,85]. This study demonstrates that MSCs and Schwann cells can attach to TiSAMP and deposit ECM. This study provides a great regenerative medicine tool that can be used in vitro for cell characterization or in vivo for axon guidance, neuroprosthetics and devices production, or the future delivery of cells and patterned ECM.
5. Methods
5.1. OPF Sheet Fabrication
OPF was synthesized as previously characterized and described [13,27,28,86]. Briefly, a liquid OPF polymer composed of 1g of OPF macromere (16,246 g/mol), 950 µL deionized water, 0.3 g N-vinyl pyrrolidinone (NVP; Sigma Aldrich, St. Louis, MO, USA), and 0.05% (w/w) photoinitiator (Irgacure 2959; Ciba Specialty Chemicals, Basel, Switzerland) was made. A 0.08 mm thin OPF sheet with 0.1 mm high ridges was created using a Teflon mold, with a 0.08 mm spacer and grooves of 0.1 mm depth spaced 1 mm or 0.4 mm apart. The polymer was slowly pipetted onto the mold and covered with a glass plate. The mold was placed in a UV light oven for 1 h and cured overnight in the dark. The single-channel OPF scaffold was fabricated via the mold injection of the polymer, and then cast over a 1 mm wire. The single channel scaffold was then polymerized via exposure to an ultra-violet (UV) light (365 nm) for one hour and cured overnight. The scaffolds were cut into 2 mm lengths for transplantation. Similarly, for the seven-channel scaffold, the polymer was mold injected over 7 equally spaced 290 µm wires in a glass cylinder and cut into 2 mm lengths for transplantation.
5.2. OPF Polymer Chemical Micropatterning
Chemical processing was performed on the opposite side of the ridge surface of the OPF sheets (Figure 1) as previously described [17]. Briefly, in an inert atmosphere glovebox with low oxygen (0.3 ppm) and moisture (0.5 ppm) (OMNI-LAB Glove Box System, Vacuum Atmospheres Company, Hawthorne, CA, USA), a solution of 30 μL of titanium (IV) isopropoxide (CAS: 546-88-9) was mixed with 5 mL anhydrous toluene (CAS: 108-88-3). A hydrolysis reaction created a surface of TiO2 on the hydrogel for bonding with phosphonic acid. The phosphonic acid solution was created by mixing 1 mg of 12-(phosphonododecyl) phosphonic acid (CAS: 7450-59-1) with 5 mL anhydrous toluene. OPF sheets were hydrated and positions on glass slides, with the excess water blotted off. To create a pattern, a Kapton shadow mask with laser ablated slits of 30 μm and spaced with 30 μm material was placed on the OPF sheet. The sheet with the mask (or without the mask for fully coated sheets) was heated to 30 °C for 15 s and placed in the TiO2 for 30 s, followed by a rinse in toluene. The material was then heated to 30 °C for 30 s. The material was then placed into the phosphonic acid solution overnight, yielding a self-assembled monolayer of phosphonic acid (SAMP) on top of the TiO2 layer (TiSAMP). The scaffold was then rinsed in toluene, followed by isopropanol, and then distilled water. The mask was then removed and heated to 30 °C for 30 s. The sheets were then kept in double-distilled water until use.
5.3. Human MSC Isolation and Culture
Human MSCs (hMSCs) were isolated from adipose tissue biopsies, and then cultured, expanded, characterized, and cryopreserved by staff at the Mayo Clinic Human Cellular Therapy Laboratory as previously described in [87,88]. The release criteria included culture sterility, mycoplasma testing, and cytogenetic analysis, as well as cellular phenotyping, including CD90+, CD105+. CD73+, HLA Class I+, CD14+, CD44+, HLA DR, and CD45-. Cells were cultured in advance MEM media (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) supplemented with human platelet lysate (5%; Lawson, Mill Creek, WA, USA), 100 U/mL Antibiotic-Antimycotic (Gibco Thermo Fisher Scientific, USA), 100 units/mL Glutamax (Gibco Thermo Fisher Scientific, USA), and 1000 USP units heparin (Novaplus, Lake Zurich, IL, USA) at 5% CO2 and 37 °C.
5.4. Rat Schwann Cell Isolation and Culture
Rat Schwann cells were harvested from the sciatic nerve of 2–5-day-old Sprague Dawley pups as previously described [13,33,34,89,90]. The cells were cultured in DMEM/F12 (Gibco, Thermo Fisher Scientific, USA) containing 10% fetal bovine serum (FBS; Gibco, Thermo Fisher Scientific, USA), 100 U/mL Antibiotic-Antimycotic (Gibco Thermo Fisher Scientific, USA), 2 μM Forskolin (Sigma Aldrich, USA), and 10 ng/mL neuregulin-1 (R&D, Minneaplois, MN, USA) at 5% CO2 and 37 °C.
5.5. Co-Culture hMSC and Schwann Cells
For the co-culture experiments, first, the cells were grown alone as described above. Once they reached 80% confluence, they were cultured on scaffold sheets at a 1:1 ratio (75,000 cells per cell type). The co-culture medium of hMSCs and Schwann cells was composed of DMEM/F12 with L glutamine media (Gibco, Thermo Fisher Scientific, USA), Forskilin (2 µM; Sigma Aldrich, USA), Neuroregulin (10 ng/mL; R&D, USA), 10% FBS (Gibco, Thermo Fisher Scientific, USA), and 1% antibiotic/antimycotic (Gibco, Thermo Fisher Scientific, USA).
5.6. Disassociated Rat Dorsal Root Ganglion Neurons
On day 15, embryonic Sprague Dawley rats were used to isolate the dorsal root ganglions (DRGs; previously described in [13,91,92]). Approximately 200 whole DRGs were pooled, and then dissociated via mechanical trituration in trypsin. Each scaffold was plated with 50,000 cells in MEM (Gibco, Thermo Fisher Scientific, USA) supplemented with 15% calf bovine serum (Hyclone, San Angelo, Texas, USA), 5 ng/mL nerve growth factor (Harlan Bioproducts, Indianapolis, IN, USA), 7 mg/mL glucose (Sigma Aldrich, USA), and 1.2 mM L-glutamine (Gibco, Thermo Fisher Scientific, USA). To obtain a pure culture of neurons, the cells were treated with 1 × 10−5 M 5-fluoro-2-deoxy-uridine and with 1 × 10−5 M uridine (Sigma Aldrich, USA) for 3 days. Two days after the treatment, neurons were fixed in 4% paraformaldehyde in PBS for 30 min and washed 3 times in PBS before the immunocytochemistry step.
5.7. OPF Preparation and Cell Seeding
Positively charged OPF (OPF+) sheets were created via the polymer containing 1 g of OPF macromere (16,246 g/mol), 650 µL deionized water, 0.3 g NVP (Sigma Aldrich, USA), and 0.05% (w/w) photoinitiator (Irgacure 2959; Ciba Specialty Chemicals, Basel, Switzerland), and 20% w/w 2-(methacryloyloxy)ethyl]-trimethylammonium chloride (MAETAC, Sigma-Aldrich, USA). The positively charged OPF+ sheets were only used in the study of the cells’ interactions with topography and stiffness, where chemical TiSAMP patterning was not introduced as a modification. A positive charge can help with cell attachment and outgrowth [86], but it may interfere with chemical patterning. OPF or OPF+ was hydrated in culture media and was pinned to sterile culture dishes containing SYLGARD 184 Silicone Elastomer (Dow Corning, Midland, MI, USA) to prevent the spontaneous rolling of the scaffold. The plates were sterilized after 20 min exposure to UV and multiple ethanol washes before pinning, while the scaffold sheets were sterilized via multiple isopropanol washes. OPF sheets were coated with either media only, poly-l-lysine (PLL; Sigma Aldrich, USA; 0.01%; 5 min), laminin (100 μg/mL; Sigma-Aldrich, USA), or rat plasma fibronectin (10 μg/mL) at 37 °C overnight. Fibronectin was isolated from rat serum using gelatin Sepharose affinity chromatography as previously described [18]. The excess ECM protein coat or PLL was removed after 3 washes with culture media specific to the cell type that would be plated. Once the cells were 70–80% confluent, 150,000 cells were seeded onto each OFP sheet for 7 days. Co-cultured cells (50:50) were plated with 75,000 cells of each type. Three sheets per condition were used. The OPF sheets with cells were fixed using 4% paraformaldehyde in phosphate-buffered saline for 20 min. Three (3) washes with PBS were performed to remove excess PFA, and then immunocytochemistry was performed.
5.8. Immunocytochemistry of Mincultured Cells on Scaffolds
Non-specific binding sites were blocked using a solution containing PBS, 10% normal donkey serum, and 0.3% Triton X-100 for 30 min. Then, scaffolds containing cells were incubated with rabbit α fibronectin (1:100; R184), mouse α laminin (1:100; 2E8; Developmental Studies Hybridoma Bank, USA [93]), and mouse α β-tubulin (1:300; Millipore Sigma, Burlington, MA, USA) overnight at 4 °C. Then, the samples were washed 3 times with PBS, and then incubated for 1 h with the donkey α mouse Cy3 (1:200; Millipore Sigma, USA), donkey α rabbit Cy5 (1:200; Millipore Sigma, USA), and phalloidin conjugated to Alexa 488 (1:100; Molecular Probes, Eugene, OR, USA) at room temperature. Then, the samples were washed 3 times in PBS before being placed on a slide and coverslip in SlowFade Gold containing DAPI (Invitrogen, Waltham, MA, USA). In the case of cells grown on coverslips, they were inverted onto a glass slide with SlowFade Gold containing DAPI (Invitrogen, USA) following the same procedure above.
5.9. Image Acquisition for Scaffold Sheets
Fluorescent images were acquired using an inverted fluorescence microscope Zeiss Axio Observer Z-1 with a motorized stage that had an Axiocam 503 camera mounted on it (Carl Zeiss, Oberkochen, Germany). Zen (v2, blue edition; Carl Zeiss, Germany) software was used to acquire and process the images. Z-stacks with approximately 5 slides were taken at 20×. Bright-field images of live cultures were taken on a Zeiss Axiovert Model 35 microscope with a Nikon CCD camera at 10× magnification (Carl Zeiss, Germany). On each OPF sheet or coverslip, 4 representative areas were taken in a non-biased manner by moving one field of view up or down from a central position and 2 fields of view across. Three to four different replicates were used for each condition (three to four scaffolds or coverslips).
5.10. Analysis of Laminin and Fibronectin Deposit by Schwann Cells and MSCs on Scaffolds in Culture
Fluorescent images were analyzed using ImageJ (v1.53) software (National Institutes of Health, Bethesda, MD, USA). Fluorescence intensity was measured as previously described [13]. Briefly, images type was set to 8-bit, and the mean grey value of laminin and fibronectin was measured. The mean grey value of laminin and fibronectin was then normalized to the mean grey value of DAPI staining per cell. One-way ANOVA with Tukey’s multiple comparisons was performed to determine statistical significance. Four representative areas were taken in a non-biased manner by moving one field of view up or down from a central position and 2 fields of view across. Four different replicates were used for each condition (four scaffolds or coverslips).
5.11. Scaffold Preparation and Surgical Implantation
OPF sheets and single-channel scaffolds were sterilized with a serial dilution of isopropanol. Two (2) mm by six mm OPF sheets were rolled and placed into the single channel scaffold. Female Sprague Dawley rats (230–300 g; Envigo, Indianapolis, IN, USA) received a laminectomy at level T9, and complete spinal cord transection was performed. The scaffold was placed in the transected area, and all the muscles were sutured closed. The rats were divided into 4 groups that were implanted with either untreated rolled OPF sheets (OPF; n = 7), fully coated TiSAMP OPF sheets (full TiSAMP; n = 7), patterned TiSAMP sheets with 30 μm thick chemical and 30 μm thick polymer spacing (30 × 30 TiSAMP; n = 7), or seven-channel OPF (n = 8) scaffolds. The animals were cared for daily by veterinarians and other staff experienced in the care of rats with spinal cord injuries. All procedures were approved by the Mayo Clinic Institutional Animal Care and Use Committee, and all guidelines were followed in accordance with the National Institute of Health, Institute for Laboratory Animal Research, the United States Public Health Services Policy, on the Humane Care and Use of Laboratory Animals, and ARRIVE.
5.12. Basso, Beattie, and Bresnahan (BBB) Locomotor Score
The BBB open field locomotor test [34,94] was conducted weekly following the injuries to access hindlimb function. Two blinded observers rated aspects of the hind-limb function, which was scored on a 21-point scale. BBB scores were averaged between the observers, as well as the left- and right-side scores. Two-way ANOVA with Tukey’s multiple comparisons was used to determine statistical differences between the groups.
5.13. Tissue Preparation and Immunohistochemistry
The animals were euthanized using anesthesia and fixed via transcardial perfusion with 4% paraformaldehyde in PBS. The spinal column was removed en bloc and post-fixed for 2 days at 4 °C. The spinal cords were dissected out, and a 1 cm segment with scaffold (T9) in the center was embedded in paraffin. Transverse sections 10 μm thick were cut using a Reichert-Jung Biocut microtome (Leica, Bannockburn, IL, USA).
The tissue sections were deparaffinized using serial dilutions of xylene and ethanol. Antigen retrieval was performed by immersing the slides in 1 mM EDTA in PBS (pH 8.0), and then placing them in a streamer for 30 min. The tissue was then permeabilized with PBS containing 0.3% Triton X-100. Then, blocking solution containing PBS with 0.3% Triton X-100 and 10% normal donkey serum was placed on the tissue for 30 min to block non-specific binding sites. Then, the sections were incubated using the primary antibodies, rabbit α fibronectin (1:100; R184), mouse α laminin (1:100; 2E8; Developmental Studies Hybridoma Bank, USA [93]), mouse α β-tubulin (1:300; Millipore Sigma, USA), mouse α CD45 (1:50; Agilent DAKO, Santa Clara, CA, USA), and rabbit α Iba-1 (1:800; Wako FUJI Film, Richmond, VA, USA), overnight at 4 °C. The sections were then serially washed with PBS containing 0.1% Triton X-100. Secondary antibodies, donkey α mouse Cy3 (1:200; Jackson ImmunoResearch Laboratories, West Grove, PA, USA) and donkey α rabbit Alexa 647 (1:200; Jackson ImmunoResearch Laboratories, USA), were then placed on the sections for 1 h at room temperature. The secondary antibodies were washed off using PBS, and then cover slipped with SlowFade Gold containing DAPI (Invitrogen, USA).
5.14. Trichrome Staining
Trichrome staining was performed using a Masson Trichrome Staining Kit (Richard-Allan Scientific, San Diego, CA, USA). The samples were first deparaffinized using serial dilutions of xylene and ethanol. The sections were then placed in Bouin’s fluid for 1 h at 56 °C. After a 5 min rinse in tap water, the slides were placed in working Weigert’s solution for 10 min. Following a 5 min rinse in tap water, the slides were then placed in Biebrich Scarlet solution for 5 min. The slides were then rinsed in distilled water for 30 s, followed by immersion into Phosphotungstic-Phosphomolybdic Acid for 5 min and Aniline Blue for 5 min. Then, samples were then washed in 1% Acetic acid for 1 min and rinsed in distilled water for 30 s. Lastly, the samples were then washed in 100% ethanol twice and xylene 3 times for I minute each. The slides were then mounted with a mounting medium (Richard-Allan Scientific, San Diego, CA, USA).
5.15. Image Acquisition
Immunofluorescent imaging was performed using a Zeiss LSM 780 Confocal Microscope (Carl Zeiss, Germany) with a motorized stage using Zeiss Zen (v2, blue edition) software. Whole transverse sections were imaged using a Plan Apochromat 20x/0.8 M27 objective. Light microscopy was performed using a Zeiss Axio Scanner Z1 (Carl Zeiss, Germany) with the Zen (v2, Blue edition) software. All sections on the slide were scanned using the automated tissue detector feature in Zen (v2, blue edition) software.
5.16. Axon Count
Axons were identified via characteristic punctate staining with β-III tubulin by a blinded investigator. Axons were counted on the whole transverse section at quarter lengths throughout the scaffold. Tiled 20× images were loaded into the QuPath (v0.3.2) Software [29], and a grid was overlayed on the image. Using the point tool, axons were manually counted by a blinded investigator. was Axons were counted if they were in the quadrant or overlapped on the top horizontal or right vertical boundary. The area of the scaffold was measured by tracing the scaffold boundary. The axons counts were then averaged throughout the quarter lengths of the scaffold and normalized to area for each rat. One-way ANOVA with Tukey’s multiple comparisons was used to determine differences between the groups, and the errors are represented as ±SEM.
5.17. Quantification of Laminin and Fibronectin Components of the ECM in Implanted Scaffolds
A blinded investigator used ImageJ (National Institutes of Health, USA) to calculate the laminin and fibronectin stained areas in the fluorescent images throughout the quarter length of the scaffold. First, the region of interest around the scaffold was marked. The image was changed to 8-bit, and a threshold was set to select the staining in each channel. A percent area was calculated from the area stained to the area of the region of interest. Data represent quarter lengths or averages throughout the scaffold regions for each rat. One-way ANOVA was performed to determine differences between the conditions with the error represented as ± SEM.
5.18. Machine Learning Analysis of Immune Cell Infiltration and Fibrotic Scarring
For the image analysis of immune cell infiltration (CD45+ cells and Iba-1+ cells), a neural network was implemented using QuPath (v0.3.2).software, which represents a fast, unbiased, and reproducible way to analyze microscopy images (Supplementary Figure S3). To identify the region of interest, a simple threshold pixel classifier was created to annotate the tissue section. Next, we configured a watershed cell detection algorithm to detect cells based on the intensity values of the DAPI channel. To enable more accurate classification, additional features were calculated for each cell, including the standard deviation of stain intensity for each stain, circularity, and perimeter. In the last step, we trained two separate networks on a large subset of training data produced by manually annotating cells for each antibody. Both neural networks were later combined into a composite classifier that could differentiate between CD45+ cells, Iba-1+-positive cells, cells positive for both markers, and cells negative for both markers. The data are represented as an average of all the quarter lengths throughout the scaffold per rat or counts at each quarter length for each rat. One-way or Two-way ANOVA with Tukey’s multiple comparisons was used where appropriate.
For the image analysis of the fibrotic collagen scar area, a color deconvolution-based technique was implemented in QuPath (v0.3.2) for bright-field images (Supplementary Figure S4). First, the stain vectors were estimated using pixel values to separate out Analine blue stain from the Biebrich Scarlet Stain. A simple pixel threshold classifier was used (as explained for immunofluroscent images) to detect the tissue area. Then, color deconvolution was performed to calculate the percent area of scarred tissue (more detailed methodology is available in the Supplementary Information). Measurements for the whole tissue area and scar area were exported, and percentages for fibrotic, scarred area were obtained by dividing scarred tissue area by the whole tissue area. One-way or Two-way ANOVA with Tukey’s multiple comparisons was used where appropriate.
5.19. Statistical Analysis
All data are reported as the mean ± standard error of the mean (SEM), and analysis was conducted using GraphPad Prism (v9, GraphPad Software Inc.). Statistical significance was calculated using One-way or Two-way ANOVA with Tukey’s multiple comparisons as appropriate. One-way ANOVA was used to determine how one factor affects a response to a variable in a group of 3 or more. Two-way ANOVA was used to determine how 2 factors affect a variable and the interaction of the factors on the variable. All experiments were determined to meet the assumptions of ANOVA testing, with the data having normal variance and distribution. For in vitro experiments, 3 groups were compared (hMSCs, Schwann cells, and combined), while for in vivo experiments, 4 groups were compared (OPF, full TiSAMP, 30 × 30 TiSAMP, and seven-channel scaffolds). Each animal group had 7–8 rats. For the histological analysis of scaffolds, tiled images at ¼, ½, and ¾ lengths were taken and either analyzed separately or averaged. A p-value of 0.05 was used to determine statistical significance. The graphical representation of the p value is represented as * p < 0.05, ** p < 0.01, *** p < 0.001, or **** p < 0.0001, unless otherwise stated in the figure caption.
Supplementary Materials
The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms241210250/s1, [95,96,97,98,99,100].
Author Contributions
Conceptualization, A.M.S., J.E.S., J.S., M.J.Y., A.J.W. and N.N.M.; performed experiments, A.M.S., F.T., R.N.S., S.R., G.J.W., T.S., B.K.C., J.J.N., J.L.S. and K.L.; analyzed data, A.M.S., F.T., R.N.S. and G.J.W.; writing—original draft preparation, A.M.S.; writing—review and editing, A.M.S., J.E.S., J.S., A.J.W. and N.N.M. (all authors had final input); visualization, A.M.S.; supervision, A.M.S., J.E.S., J.S., A.J.W., M.J.Y. and N.N.M.; project administration, J.E.S., J.S., M.J.Y., A.J.W. and N.N.M.; funding acquisition, J.E.S., J.S., M.J.Y., A.J.W. and N.N.M. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
The animal study protocol was approved by the Institutional Animal Care & Use Committee of Mayo Clinic (protocol code A00002147, approved: 25 August 2016, renewed: 15 July 2022).
Informed Consent Statement
Not applicable.
Data Availability Statement
All data are available on reasonable request. Contact Nicolas Madigan (madigan.nicolas@mayo.edu) for requests.
Conflicts of Interest
The authors have no competing interest to report.
Funding Statement
This research was funded by grants from the New Jersey Commission on Spinal Cord Research, CSCR15IRG002, the National Center for Advancing Translational Sciences, (NCATS) UL1 TR002377 and TL1 TR002380, Mayo Clinic Benefactor Funded Career Development Award–Regenerative Medicine Initiative, and National Institute of Arthritis and Musculoskeletal and Skin Disease (R01AR073236). It was also supported by grants from the Bowen Foundation, the Kipnis Foundation, Nemitz Foundation, and the Mayo Clinic Center for Regenerative Medicine, and the New Ideas in the Natural Sciences Award from the Princeton Dean of Research.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Siddiqui A.M., Ahuja C.S., Tator C.H., Fehlings M.G. Chapter 3: Spinal cord protective and regenerative therapies. In: Jallo J., Vaccaro A., editors. Neurotrauma and Critical Care of the Spine. 2nd ed. Thieme; New York, NY, USA: 2018. pp. 12–30. [Google Scholar]
- 2.Madigan N.N., McMahon S., O’Brien T., Yaszemski M.J., Windebank A.J. Current tissue engineering and novel therapeutic approaches to axonal regeneration following spinal cord injury using polymer scaffolds. Respir. Physiol. Neurobiol. 2009;169:183–199. doi: 10.1016/j.resp.2009.08.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Putra R.U., Basri H., Prakoso A.T., Chandra H., Ammarullah M.I., Akbar I., Syahrom A., Kamarul T. Level of Activity Changes Increases the Fatigue Life of the Porous Magnesium Scaffold, as Observed in Dynamic Immersion Tests, over Time. Sustainability. 2023;15:823. doi: 10.3390/su15010823. [DOI] [Google Scholar]
- 4.Madigan N.N., Windebank A.J. Principles of Tissue Engineering. Elsevier; Amsterdam, The Netherlands: 2020. Spinal cord injury; pp. 1047–1091. [Google Scholar]
- 5.Wong D.Y., Leveque J.C., Brumblay H., Krebsbach P.H., Hollister S.J., Lamarca F. Macro-architectures in spinal cord scaffold implants influence regeneration. J. Neurotrauma. 2008;25:1027–1037. doi: 10.1089/neu.2007.0473. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Moore M.J., Friedman J.A., Lewellyn E.B., Mantila S.M., Krych A.J., Ameenuddin S., Knight A.M., Lu L., Currier B.L., Spinner R.J., et al. Multiple-channel scaffolds to promote spinal cord axon regeneration. Biomaterials. 2006;27:419–429. doi: 10.1016/j.biomaterials.2005.07.045. [DOI] [PubMed] [Google Scholar]
- 7.Stokols S., Sakamoto J., Breckon C., Holt T., Weiss J., Tuszynski M.H. Templated agarose scaffolds support linear axonal regeneration. Tissue Eng. 2006;12:2777–2787. doi: 10.1089/ten.2006.12.2777. [DOI] [PubMed] [Google Scholar]
- 8.Krych A.J., Rooney G.E., Chen B., Schermerhorn T.C., Ameenuddin S., Gross L., Moore M.J., Currier B.L., Spinner R.J., Friedman J.A., et al. Relationship between scaffold channel diameter and number of regenerating axons in the transected rat spinal cord. Acta Biomater. 2009;5:2551–2559. doi: 10.1016/j.actbio.2009.03.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Koffler J., Zhu W., Qu X., Platoshyn O., Dulin J.N., Brock J., Graham L., Lu P., Sakamoto J., Marsala M. Biomimetic 3D-printed scaffolds for spinal cord injury repair. Nat. Med. 2019;25:263. doi: 10.1038/s41591-018-0296-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Winter C.C., Katiyar K.S., Hernandez N.S., Song Y.J., Struzyna L.A., Harris J.P., Cullen D.K. Transplantable living scaffolds comprised of micro-tissue engineered aligned astrocyte networks to facilitate central nervous system regeneration. Acta Biomater. 2016;38:44–58. doi: 10.1016/j.actbio.2016.04.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Agrawal L., Saidani M., Guillaud L., Terenzio M. Development of 3D culture scaffolds for directional neuronal growth using 2-photon lithography. Mater. Sci. Eng. C. 2021;131:112502. doi: 10.1016/j.msec.2021.112502. [DOI] [PubMed] [Google Scholar]
- 12.Bryant S.J., Cuy J.L., Hauch K.D., Ratner B.D. Photo-patterning of porous hydrogels for tissue engineering. Biomaterials. 2007;28:2978–2986. doi: 10.1016/j.biomaterials.2006.11.033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Siddiqui A.M., Brunner R., Harris G.M., Miller A.L., 2nd, Waletzki B.E., Schmeichel A.M., Schwarzbauer J.E., Schwartz J., Yaszemski M.J., Windebank A.J., et al. Promoting Neuronal Outgrowth Using Ridged Scaffolds Coated with Extracellular Matrix Proteins. Biomedicines. 2021;9:479. doi: 10.3390/biomedicines9050479. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Miller C., Jeftinija S., Mallapragada S. Micropatterned Schwann cell-seeded biodegradable polymer substrates significantly enhance neurite alignment and outgrowth. Tissue Eng. 2001;7:705–715. doi: 10.1089/107632701753337663. [DOI] [PubMed] [Google Scholar]
- 15.Di Luca A., de Wijn J.R., van Blitterswijk C.A., Camarero-Espinosa S., Moroni L. Tailorable surface morphology of 3D scaffolds by combining additive manufacturing with thermally induced phase separation. Macromol. Rapid Commun. 2017;38:1700186. doi: 10.1002/marc.201700186. [DOI] [PubMed] [Google Scholar]
- 16.Park C.H., Kim K.-H., Lee Y.-M., Giannobile W.V., Seol Y.-J. 3D Printed, Microgroove Pattern-Driven Generation of Oriented Ligamentous Architectures. Int. J. Mol. Sci. 2017;18:1927. doi: 10.3390/ijms18091927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Chen J.W., Lim K., Bandini S.B., Harris G.M., Spechler J.A., Arnold C.B., Fardel R., Schwarzbauer J.E., Schwartz J. Controlling the Surface Chemistry of a Hydrogel for Spatially Defined Cell Adhesion. ACS Appl. Mater. Interfaces. 2019;11:15411–15416. doi: 10.1021/acsami.9b04023. [DOI] [PubMed] [Google Scholar]
- 18.Harris G.M., Madigan N.N., Lancaster K.Z., Enquist L.W., Windebank A.J., Schwartz J., Schwarzbauer J.E. Nerve Guidance by a Decellularized Fibroblast Extracellular Matrix. Matrix Biol. 2017;60–61:176–189. doi: 10.1016/j.matbio.2016.08.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Ratner B.D. A pore way to heal and regenerate: 21st century thinking on biocompatibility. Regen. Biomater. 2016;3:107–110. doi: 10.1093/rb/rbw006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Homsy C.A. Bio-Compatibility in selection of materials for implantation. J. Biomed. Mater. Res. 1970;4:341–356. doi: 10.1002/jbm.820040306. [DOI] [PubMed] [Google Scholar]
- 21.Silva M., Cyster L., Barry J., Yang X., Oreffo R., Grant D., Scotchford C., Howdle S., Shakesheff K., Rose F. The effect of anisotropic architecture on cell and tissue infiltration into tissue engineering scaffolds. Biomaterials. 2006;27:5909–5917. doi: 10.1016/j.biomaterials.2006.08.010. [DOI] [PubMed] [Google Scholar]
- 22.Thevenot P.T., Nair A.M., Shen J., Lotfi P., Ko C.-Y., Tang L. The effect of incorporation of SDF-1α into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials. 2010;31:3997–4008. doi: 10.1016/j.biomaterials.2010.01.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Mountziaris P.M., Mikos A.G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng. Part B Rev. 2008;14:179–186. doi: 10.1089/ten.teb.2008.0038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Tu Z., Zhong Y., Hu H., Shao D., Haag R., Schirner M., Lee J., Sullenger B., Leong K.W. Design of therapeutic biomaterials to control inflammation. Nat. Rev. Mater. 2022;7:557–574. doi: 10.1038/s41578-022-00426-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Chen H., Agrawal D.K., Thankam F.G. Biomaterials-driven sterile inflammation. Tissue Eng. B Rev. 2022;28:22–34. doi: 10.1089/ten.teb.2020.0253. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Zindel J., Kubes P. DAMPs, PAMPs, and LAMPs in immunity and sterile inflammation. Annu. Rev. Pathol. Mech. Dis. 2020;15:493–518. doi: 10.1146/annurev-pathmechdis-012419-032847. [DOI] [PubMed] [Google Scholar]
- 27.Dadsetan M., Szatkowski J.P., Yaszemski M.J., Lu L. Characterization of photo-cross-linked oligo[poly(ethylene glycol) fumarate] hydrogels for cartilage tissue engineering. Biomacromolecules. 2007;8:1702–1709. doi: 10.1021/bm070052h. [DOI] [PubMed] [Google Scholar]
- 28.Chen B.K., Knight A.M., Madigan N.N., Gross L., Dadsetan M., Nesbitt J.J., Rooney G.E., Currier B.L., Yaszemski M.J., Spinner R.J., et al. Comparison of polymer scaffolds in rat spinal cord: A step toward quantitative assessment of combinatorial approaches to spinal cord repair. Biomaterials. 2011;32:8077–8086. doi: 10.1016/j.biomaterials.2011.07.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Hakim J.S., Esmaeili Rad M., Grahn P.J., Chen B.K., Knight A.M., Schmeichel A.M., Isaq N.A., Dadsetan M., Yaszemski M.J., Windebank A.J. Positively Charged Oligo[Poly(Ethylene Glycol) Fumarate] Scaffold Implantation Results in a Permissive Lesion Environment after Spinal Cord Injury in Rat. Tissue Eng. A. 2015;21:2099–2114. doi: 10.1089/ten.tea.2015.0019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Rooney G.E., Knight A.M., Madigan N.N., Gross L., Chen B., Giraldo C.V., Seo S., Nesbitt J.J., Dadsetan M., Yaszemski M.J., et al. Sustained Delivery of Dibutyryl Cyclic Adenosine Monophosphate to the Transected Spinal Cord Via Oligo [(Polyethylene Glycol) Fumarate] Hydrogels. Tissue Eng A. 2011;17:1287–1302. doi: 10.1089/ten.tea.2010.0396. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Runge M.B., Dadsetan M., Baltrusaitis J., Ruesink T., Lu L., Windebank A.J., Yaszemski M.J. Development of Electrically Conductive Oligo(polyethylene glycol) Fumarate-Polypyrrole Hydrogels for Nerve Regeneration. Biomacromolecules. 2010;11:2845–2853. doi: 10.1021/bm100526a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Madigan N.N., Chen B.K., Knight A.M., Rooney G.E., Sweeney E., Kinnavane L., Yaszemski M.J., Dockery P., O’Brien T., McMahon S.S., et al. Comparison of cellular architecture, axonal growth, and blood vessel formation through cell-loaded polymer scaffolds in the transected rat spinal cord. Tissue Eng. A. 2014;20:2985–2997. doi: 10.1089/ten.tea.2013.0551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Siddiqui A.M., Oswald D., Papamichalopoulos S., Kelly D., Summer P., Polzin M., Hakim J., Schmeichel A.M., Chen B., Yaszemski M.J., et al. Defining spatial relationships between spinal cord axons and blood vessels in hydrogel scaffolds. Tissue Eng. A. 2021;27:648–664. doi: 10.1089/ten.tea.2020.0316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Siddiqui A.M., Islam R., Cuellar C.A., Silvernail J.L., Knudsen B., Curley D.E., Strickland T., Manske E., Suwan P.T., Latypov T., et al. Newly regenerated axons via scaffolds promote sub-lesional reorganization and motor recovery with epidural electrical stimulation. NPJ Regen. Med. 2021;6:66. doi: 10.1038/s41536-021-00176-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Chen B.K., Madigan N.N., Hakim J.S., Dadsetan M., McMahon S.S., Yaszemski M.J., Windebank A.J. GDNF Schwann cells in hydrogel scaffolds promote regional axon regeneration, remyelination and functional improvement after spinal cord transection in rats. J. Tissue Eng. Regen. Med. 2018;12:e398–e407. doi: 10.1002/term.2431. [DOI] [PubMed] [Google Scholar]
- 36.Carnicer-Lombarte A., Chen S.-T., Malliaras G.G., Barone D.G. Foreign Body Reaction to Implanted Biomaterials and Its Impact in Nerve Neuroprosthetics. Front. Bioeng. Biotechnol. 2021;9:271. doi: 10.3389/fbioe.2021.622524. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Hakim J.S., Rodysill B.R., Chen B.K., Schmeichel A.M., Yaszemski M.J., Windebank A.J., Madigan N.N. Combinatorial tissue engineering partially restores function after spinal cord injury. J. Tissue Eng. Regen. Med. 2019;13:857–873. doi: 10.1002/term.2840. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Krupa P., Siddiqui A.M., Grahn P.J., Islam R., Chen B.K., Madigan N.N., Windebank A.J., Lavrov I.A. The Translesional Spinal Network and Its Reorganization after Spinal Cord Injury. Neuroscientist. 2022;28:163–179. doi: 10.1177/1073858420966276. [DOI] [PubMed] [Google Scholar]
- 39.Slaughter B.V., Khurshid S.S., Fisher O.Z., Khademhosseini A., Peppas N.A. Hydrogels in regenerative medicine. Adv. Mater. 2009;21:3307–3329. doi: 10.1002/adma.200802106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Gombotz W.R., Wang G.H., Horbett T.A., Hoffman A.S. Protein adsorption to poly(ethylene oxide) surfaces. J. Biomed. Mater. Res. 1991;25:1547–1562. doi: 10.1002/jbm.820251211. [DOI] [PubMed] [Google Scholar]
- 41.Liu S., Xie Y.Y., Wang B. Role and prospects of regenerative biomaterials in the repair of spinal cord injury. Neural Regen. Res. 2019;14:1352–1363. doi: 10.4103/1673-5374.253512. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Li G., Che M.T., Zhang K., Qin L.N., Zhang Y.T., Chen R.Q., Rong L.M., Liu S., Ding Y., Shen H.Y., et al. Graft of the NT-3 persistent delivery gelatin sponge scaffold promotes axon regeneration, attenuates inflammation, and induces cell migration in rat and canine with spinal cord injury. Biomaterials. 2016;83:233–248. doi: 10.1016/j.biomaterials.2015.11.059. [DOI] [PubMed] [Google Scholar]
- 43.Huang L., Wang Y., Zhu M., Wan X., Zhang H., Lei T., Blesch A., Liu S. Anisotropic Alginate Hydrogels Promote Axonal Growth across Chronic Spinal Cord Transections after Scar Removal. ACS Biomater. Sci. Eng. 2020;6:2274–2286. doi: 10.1021/acsbiomaterials.9b01802. [DOI] [PubMed] [Google Scholar]
- 44.Gros T., Sakamoto J.S., Blesch A., Havton L.A., Tuszynski M.H. Regeneration of long-tract axons through sites of spinal cord injury using templated agarose scaffolds. Biomaterials. 2010;31:6719–6729. doi: 10.1016/j.biomaterials.2010.04.035. [DOI] [PubMed] [Google Scholar]
- 45.Zhang J., Cheng T., Chen Y., Gao F., Guan F., Yao M. A chitosan-based thermosensitive scaffold loaded with bone marrow-derived mesenchymal stem cells promotes motor function recovery in spinal cord injured mice. Biomed. Mater. 2020;15:035020. doi: 10.1088/1748-605X/ab785f. [DOI] [PubMed] [Google Scholar]
- 46.Yeh J.Z., Wang D.H., Cherng J.H., Wang Y.W., Fan G.Y., Liou N.H., Liu J.C., Chou C.H. A Collagen-Based Scaffold for Promoting Neural Plasticity in a Rat Model of Spinal Cord Injury. Polymers. 2020;12:2245. doi: 10.3390/polym12102245. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Kushchayev S.V., Giers M.B., Hom Eng D., Martirosyan N.L., Eschbacher J.M., Mortazavi M.M., Theodore N., Panitch A., Preul M.C. Hyaluronic acid scaffold has a neuroprotective effect in hemisection spinal cord injury. J. Neurosurg. Spine. 2016;25:114–124. doi: 10.3171/2015.9.SPINE15628. [DOI] [PubMed] [Google Scholar]
- 48.Cao Z., Yao S., Xiong Y., Zhang Z., Yang Y., He F., Zhao H., Guo Y., Wang G., Xie S., et al. Directional axonal regrowth induced by an aligned fibrin nanofiber hydrogel contributes to improved motor function recovery in canine L2 spinal cord injury. J. Mater. Sci. Mater. Med. 2020;31:40. doi: 10.1007/s10856-020-06375-9. [DOI] [PubMed] [Google Scholar]
- 49.Jarrah R., Sammak S.E., Onyedimma C., Ghaith A.K., Moinuddin F.M., Bhandarkar A.R., Siddiqui A., Madigan N., Bydon M. The Role of Alginate Hydrogels as a Potential Treatment Modality for Spinal Cord Injury: A Comprehensive Review of the Literature. Neurospine. 2022;19:272–280. doi: 10.14245/ns.2244186.093. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Libro R., Bramanti P., Mazzon E. The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration. Exp. Ther. Med. 2017;14:3355–3368. doi: 10.3892/etm.2017.4939. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Subramanian A., Krishnan U.M., Sethuraman S. Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration. J. Biomed. Sci. 2009;16:108. doi: 10.1186/1423-0127-16-108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Conova L., Vernengo J., Jin Y., Himes B.T., Neuhuber B., Fischer I., Lowman A., Vernengo J., Jin Y., Himes B.T., et al. A pilot study of poly(N-isopropylacrylamide)-g-polyethylene glycol and poly(N-isopropylacrylamide)-g-methylcellulose branched copolymers as injectable scaffolds for local delivery of neurotrophins and cellular transplants into the injured spinal cord. J. Neurosurg. Spine. 2011;15:594–604. doi: 10.3171/2011.7.SPINE11194. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Sun F., Shi T., Zhou T., Dong D., Xie J., Wang R., An X., Chen M., Cai J. 3D Poly(Lactic-co-glycolic acid) Scaffolds for Treating Spinal Cord Injury. J. Biomed. Nanotechnol. 2017;13:290–302. doi: 10.1166/jbn.2017.2348. [DOI] [PubMed] [Google Scholar]
- 54.Raynald, Shu B., Liu X.B., Zhou J.F., Huang H., Wang J.Y., Sun X.D., Qin C., An Y.H. Polypyrrole/polylactic acid nanofibrous scaffold cotransplanted with bone marrow stromal cells promotes the functional recovery of spinal cord injury in rats. CNS Neurosci. Ther. 2019;25:951–964. doi: 10.1111/cns.13135. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Li H.Y., Führmann T., Zhou Y., Dalton P.D. Host reaction to poly(2-hydroxyethyl methacrylate) scaffolds in a small spinal cord injury model. J. Mater. Sci. Mater. Med. 2013;24:2001–2011. doi: 10.1007/s10856-013-4956-8. [DOI] [PubMed] [Google Scholar]
- 56.Altinova H., Hammes S., Palm M., Gerardo-Nava J., Achenbach P., Deumens R., Hermans E., Führmann T., Boecker A., van Neerven S.G.A., et al. Fibroadhesive scarring of grafted collagen scaffolds interferes with implant-host neural tissue integration and bridging in experimental spinal cord injury. Regen. Biomater. 2019;6:75–87. doi: 10.1093/rb/rbz006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Chedly J., Soares S., Montembault A., Von Boxberg Y., Veron-Ravaille M., Mouffle C., Benassy M.-N., Taxi J., David L., Nothias F. Physical chitosan microhydrogels as scaffolds for spinal cord injury restoration and axon regeneration. Biomaterials. 2017;138:91–107. doi: 10.1016/j.biomaterials.2017.05.024. [DOI] [PubMed] [Google Scholar]
- 58.Zamani F., Amani-Tehran M., Latifi M., Shokrgozar M., Zaminy A. Promotion of spinal cord axon regeneration by 3D nanofibrous core–sheath scaffolds. J. Biomed. Mater. Res. A Off. J. Soc. Biomater. Jpn. Soc. Biomater. Aust. Soc. Biomater. Korean Soc. Biomater. 2014;102:506–513. doi: 10.1002/jbm.a.34703. [DOI] [PubMed] [Google Scholar]
- 59.Badner A., Siddiqui A.M., Fehlings M.G. Spinal cord injuries: How could cell therapy help? Expert. Opin. Biol. Ther. 2017;17:529–541. doi: 10.1080/14712598.2017.1308481. [DOI] [PubMed] [Google Scholar]
- 60.Moinuddin F.M., Yolcu Y.U., Wahood W., Siddiqui A.M., Chen B.K., Alvi M.A., Goyal A., Nesbitt J.J., Windebank A.J., Yeh J.C., et al. Early and sustained improvements in motor function in rats after infusion of allogeneic umbilical cord-derived mesenchymal stem cells following spinal cord injury. Spinal Cord. 2020;59:319–327. doi: 10.1038/s41393-020-00571-8. [DOI] [PubMed] [Google Scholar]
- 61.Schinköthe T., Bloch W., Schmidt A. In Vitro Secreting Profile of Human Mesenchymal Stem Cells. Stem Cells Dev. 2008;17:199–206. doi: 10.1089/scd.2007.0175. [DOI] [PubMed] [Google Scholar]
- 62.Buron F., Perrin H., Malcus C., Héquet O., Thaunat O., Kholopp-Sarda M.N., Moulin F.T., Morelon E. Human Mesenchymal Stem Cells and Immunosuppressive Drug Interactions in Allogeneic Responses: An In Vitro Study Using Human Cells. Transplant. Proc. 2009;41:3347–3352. doi: 10.1016/j.transproceed.2009.08.030. [DOI] [PubMed] [Google Scholar]
- 63.Redondo-Castro E., Cunningham C., Miller J., Martuscelli L., Aoulad-Ali S., Rothwell N.J., Kielty C.M., Allan S.M., Pinteaux E. Interleukin-1 primes human mesenchymal stem cells towards an anti-inflammatory and pro-trophic phenotype in vitro. Stem Cell Res. Ther. 2017;8:79. doi: 10.1186/s13287-017-0531-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Leuning D.G., Beijer N.R., Fossé N.A., Vermeulen S., Lievers E., Kooten C., Rabelink T.J., de Boer J. The cytokine secretion profile of mesenchymal stromal cells is determined by surface structure of the microenvironment. Sci. Rep. 2018;8:7716. doi: 10.1038/s41598-018-25700-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Sun M., Chi G., Li P., Lv S., Xu J., Xu Z., Xia Y., Tan Y., Xu J., Li L., et al. Effects of Matrix Stiffness on the Morphology, Adhesion, Proliferation and Osteogenic Differentiation of Mesenchymal Stem Cells. Int. J. Med. Sci. 2018;15:257–268. doi: 10.7150/ijms.21620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Yu H., Peng J., Guo Q., Zhang L., Li Z., Zhao B., Sui X., Wang Y., Xu W., Lu S. Improvement of peripheral nerve regeneration in acellular nerve grafts with local release of nerve growth factor. Microsurgery. 2009;29:330–336. doi: 10.1002/micr.20635. [DOI] [PubMed] [Google Scholar]
- 67.Bunge M.B., Wood P.M. Realizing the maximum potential of Schwann cells to promote recovery from spinal cord injury. Handb. Clin. Neurol. 2012;109:523–540. doi: 10.1016/B978-0-444-52137-8.00032-2. [DOI] [PubMed] [Google Scholar]
- 68.Gu Y., Ji Y., Zhao Y., Liu Y., Ding F., Gu X., Yang Y. The influence of substrate stiffness on the behavior and functions of Schwann cells in culture. Biomaterials. 2012;33:6672–6681. doi: 10.1016/j.biomaterials.2012.06.006. [DOI] [PubMed] [Google Scholar]
- 69.Poitelon Y., Lopez-Anido C., Catignas K., Berti C., Palmisano M., Williamson C., Ameroso D., Abiko K., Hwang Y., Gregorieff A., et al. YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells. Nat. Neurosci. 2016;19:879–887. doi: 10.1038/nn.4316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Urbanski M.M., Kingsbury L., Moussouros D., Kassim I., Mehjabeen S., Paknejad N., Melendez-Vasquez C.V. Myelinating glia differentiation is regulated by extracellular matrix elasticity. Sci. Rep. 2016;6:33751. doi: 10.1038/srep33751. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Harris G.M., Raitman I., Schwarzbauer J.E. Chapter 5—Cell-derived decellularized extracellular matrices. In: Mecham R.P., editor. Methods in Cell Biology. Volume 143. Academic Press; Cambridge, MA, USA: 2018. pp. 97–114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Novoseletskaya E., Grigorieva O., Nimiritsky P., Basalova N., Eremichev R., Milovskaya I., Kulebyakin K., Kulebyakina M., Rodionov S., Omelyanenko N., et al. Mesenchymal Stromal Cell-Produced Components of Extracellular Matrix Potentiate Multipotent Stem Cell Response to Differentiation Stimuli. Front. Cell Dev. Biol. 2020;8:555378. doi: 10.3389/fcell.2020.555378. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Liesi P. Extracellular matrix and neuronal movement. Experientia. 1990;46:900–907. doi: 10.1007/BF01939382. [DOI] [PubMed] [Google Scholar]
- 74.Calof A.L., Reichardt L.F. Response of purified chick motoneurons to myotube conditioned medium: Laminin is essential for the substratum-binding, neurite outgrowth-promoting activity. Neurosci. Lett. 1985;59:183–189. doi: 10.1016/0304-3940(85)90197-1. [DOI] [PubMed] [Google Scholar]
- 75.García-Alonso L., Fetter R.D., Goodman C.S. Genetic analysis of Laminin A in Drosophila: Extracellular matrix containing laminin A is required for ocellar axon pathfinding. Development. 1996;122:2611–2621. doi: 10.1242/dev.122.9.2611. [DOI] [PubMed] [Google Scholar]
- 76.Pankov R., Yamada K.M. Fibronectin at a glance. J. Cell Sci. 2002;115:3861–3863. doi: 10.1242/jcs.00059. [DOI] [PubMed] [Google Scholar]
- 77.Willis C.M., Crocker S.J. The Mosaic of Extracellular Matrix in the Central Nervous System as a Determinant of Glial Heterogeneity. In: Travascio F., editor. Composition and Function of the Extracellular Matrix in the Human Body. InTech; London, UK: 2016. [Google Scholar]
- 78.King V.R., Henseler M., Brown R.A., Priestley J.V. Mats made from fibronectin support oriented growth of axons in the damaged spinal cord of the adult rat. Exp. Neurol. 2003;182:383–398. doi: 10.1016/S0014-4886(03)00033-5. [DOI] [PubMed] [Google Scholar]
- 79.Shrestha B., Coykendall K., Li Y., Moon A., Priyadarshani P., Yao L. Repair of injured spinal cord using biomaterial scaffolds and stem cells. Stem Cell Res. Ther. 2014;5:91. doi: 10.1186/scrt480. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Yang F., Murugan R., Wang S., Ramakrishna S. Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials. 2005;26:2603–2610. doi: 10.1016/j.biomaterials.2004.06.051. [DOI] [PubMed] [Google Scholar]
- 81.Arguchinskaya N.V., Isaeva E.V., Kisel A.A., Beketov E.E., Lagoda T.S., Baranovskii D.S., Yakovleva N.D., Demyashkin G.A., Komarova L.N., Astakhina S.O., et al. Properties and Printability of the Synthesized Hydrogel Based on GelMA. Int. J. Mol. Sci. 2023;24:2121. doi: 10.3390/ijms24032121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Tran K.A., Partyka P.P., Jin Y., Bouyer J., Fischer I., Galie P.A. Vascularization of self-assembled peptide scaffolds for spinal cord injury repair. Acta Biomater. 2020;104:76–84. doi: 10.1016/j.actbio.2019.12.033. [DOI] [PubMed] [Google Scholar]
- 83.Teng Y.D., Lavik E.B., Qu X., Park K.I., Ourednik J., Zurakowski D., Langer R., Snyder E.Y. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc. Natl. Acad. Sci. USA. 2002;99:3024–3029. doi: 10.1073/pnas.052678899. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Lazaridou M., Bikiaris D.N., Lamprou D.A. 3D Bioprinted Chitosan-Based Hydrogel Scaffolds in Tissue Engineering and Localised Drug Delivery. Pharmaceutics. 2022;14:1978. doi: 10.3390/pharmaceutics14091978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Chiang C.E., Fang Y.Q., Ho C.T., Assuncao M., Lin S.j., Wang Y.C., Blocki A., Huang C.C. Bioactive Decellularized Extracellular Matrix Derived from 3D Stem Cell Spheroids under Macromolecular Crowding Serves as a Scaffold for Tissue Engineering. Adv. Healthcare Mater. 2021;10:2100024. doi: 10.1002/adhm.202100024. [DOI] [PubMed] [Google Scholar]
- 86.Dadsetan M., Knight A.M., Lu L., Windebank A.J., Yaszemski M.J. Stimulation of neurite outgrowth using positively charged hydrogels. Biomaterials. 2009;30:3874–3881. doi: 10.1016/j.biomaterials.2009.04.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Staff N.P., Madigan N.N., Morris J., Jentoft M., Sorenson E.J., Butler G., Gastineau D., Dietz A., Windebank A.J. Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS. Neurology. 2016;87:2230–2234. doi: 10.1212/WNL.0000000000003359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Krull A.A., Setter D.O., Gendron T.F., Hrstka S.C.L., Polzin M.J., Hart J., Dudakovic A., Madigan N.N., Dietz A.B., Windebank A.J., et al. Alterations of mesenchymal stromal cells in cerebrospinal fluid: Insights from transcriptomics and an ALS clinical trial. Stem Cell Res. Ther. 2021;12:187. doi: 10.1186/s13287-021-02241-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Olson H.E., Rooney G.E., Gross L., Nesbitt J.J., Galvin K.E., Knight A., Chen B., Yaszemski M.J., Windebank A.J. Neural stem cell- and schwann cell-loaded biodegradable polymer scaffolds support axonal regeneration in the transected spinal cord. Tissue Eng. A. 2009;15:1797–1805. doi: 10.1089/ten.tea.2008.0364. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Chen B.K., Knight A.M., de Ruiter G.C.W., Yaszemski M.J., Currier B.L., Windebank A.J. Axon regeneration through scaffold into distal spinal cord after transection. J. Neurotrauma. 2009;26:1759–1771. doi: 10.1089/neu.2008.0610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Conti A.M., Fischer S.J., Windebank A.J. Inhibition of axonal growth from sensory neurons by excess nerve growth factor. Ann. Neurol. 1997;42:838–846. doi: 10.1002/ana.410420604. [DOI] [PubMed] [Google Scholar]
- 92.Podratz J.L., Windebank A.J. NGF rescues DRG neurons in vitro from oxidative damage produced by hemodialyzers. Neurotoxicology. 2005;26:343–350. doi: 10.1016/j.neuro.2005.01.003. [DOI] [PubMed] [Google Scholar]
- 93.Engvall E., Earwicker D., Haaparanta T., Ruoslahti E., Sanes J. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from five different subunits. Cell Regul. 1990;1:731–740. doi: 10.1091/mbc.1.10.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Basso D.M., Beattie M.S., Bresnahan J.C. A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma. 1995;12:1–21. doi: 10.1089/neu.1995.12.1. [DOI] [PubMed] [Google Scholar]
- 95.Bera K., Schalper K.A., Rimm D.L., Velcheti V., Madabhushi A. Artificial intelligence in digital pathology—New tools for diagnosis and precision oncology. Nat. Rev. Clin. Oncol. 2019;16:703–715. doi: 10.1038/s41571-019-0252-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Signaevsky M., Prastawa M., Farrell K., Tabish N., Baldwin E., Han N., Iida M.A., Koll J., Bryce C., Purohit D., et al. Artificial intelligence in neuropathology: Deep learning-based assessment of tauopathy. Lab. Investig. 2019;99:1019–1029. doi: 10.1038/s41374-019-0202-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Lujan G., Quigley J.C., Hartman D., Parwani A., Roehmholdt B., Van Meter B., Ardon O., Hanna M.G., Kelly D., Sowards C., et al. Dissecting the Business Case for Adoption and Implementation of Digital Pathology: A White Paper from the Digital Pathology Association. J. Pathol. Informatics. 2021;12:17. doi: 10.4103/jpi.jpi_67_20. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Doupe P., Faghmous J., Basu S. Machine Learning for Health Services Researchers. Value Heal. 2019;22:808–815. doi: 10.1016/j.jval.2019.02.012. [DOI] [PubMed] [Google Scholar]
- 99.Rashidi H.H., Tran N.K., Betts E.V., Howell L.P., Green R. Artificial Intelligence and Machine Learning in Pathology: The Present Landscape of Supervised Methods. Acad. Pathol. 2019;6:2374289519873088. doi: 10.1177/2374289519873088. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Mao J., Luo Y., Liu L., Lao J., Shao Y., Zhang M., Zhang C., Sun M., Shen L. Automated diagnosis and quantitative analysis of plus disease in retinopathy of prematurity based on deep convolutional neural networks. Acta Ophthalmol. 2019;98:e339–e345. doi: 10.1111/aos.14264. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
All data are available on reasonable request. Contact Nicolas Madigan (madigan.nicolas@mayo.edu) for requests.